Menopause and ageing in women with multiple sclerosis

• by Cecilia Smith Simonsen, Elisabeth Gulowsen Celius

• June 9, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

• by Kathryn Wighton

• June 15, 2026

• 3 min

Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina

• by Analisa Manin, Fernanda Ingenito, Evangelina Valeria Cores, Diego Alarcón Guerrero, Silvia Graciela Ramos, Andrés M. Villa

• May 29, 2026

In Memoriam: J. Richard Baringer, MD (1935–2025)

• by John E. Greenlee, John W. Rose, Kathleen B. Digre, Mark B. Bromberg

• July 14, 2026